Astellas Pharma (4503N) Stock Forecast & Price Target
4503N Analyst Ratings
4503N Stock 12 Month Forecast
Average Price Target
MXN 304.16▲(18.84% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Macquarie | MXN 321.89 | buy | 25.77%Upside | Reiterated | 10/16/26 | ||
| Unknown AnalystNot Ranked | Daiwa | MXN 202.67→MXN 238.44 | sell | -6.84%Downside | Reiterated | 09/30/26 | ||
| Unknown AnalystNot Ranked | Mizuho Securities | MXN 290.90 | hold | 13.66%Upside | Reiterated | 09/14/26 | ||
| Unknown AnalystNot Ranked | CLSA | MXN 357.66 | buy | 39.74%Upside | Reiterated | 08/18/26 | ||
| Unknown AnalystNot Ranked | J.P. Morgan | MXN 274.21→MXN 298.05 | hold | 16.45%Upside | Reiterated | 08/17/26 | ||
| Hidemaru Yamaguchi | Citi | MXN 294.47 | hold | 15.06%Upside | Reiterated | 08/07/26 | ||
| Unknown AnalystNot Ranked | Goldman Sachs | MXN 357.66→MXN 369.58 | buy | 44.40%Upside | Reiterated | 08/06/26 | ||
| Unknown AnalystNot Ranked | Morgan Stanley | MXN 262.28 | hold | 2.48%Upside | Reiterated | 08/06/26 | ||
| Unknown AnalystNot Ranked | SBI Securities | MXN 269.44 | hold | 5.27%Upside | Reiterated | 07/29/26 | ||
| Unknown AnalystNot Ranked | UBS | MXN 286.13→MXN 274.21 | hold | 7.14%Upside | Reiterated | 07/15/26 | ||
| Miki Sogi | Bernstein | MXN 262.28 | hold | 2.48%Upside | Reiterated | 07/07/26 | ||
| Unknown AnalystNot Ranked | Bank of America Securities | MXN 321.89 | buy | 25.77%Upside | Reiterated | 06/05/26 | ||
| Stephen Barker | Jefferies | MXN 333.82 | buy | 30.43%Upside | Reiterated | 03/24/26 | ||
| Unknown AnalystNot Ranked | Nomura | MXN 286.13→MXN 298.05 | hold | 16.45%Upside | Downgraded | 02/19/26 | ||
| Unknown AnalystNot Ranked | SMBC Nikko | MXN 202.67→MXN 238.44 | hold | -6.84%Downside | Reiterated | 02/16/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 10/16/26 | MXN 321.89 | buy | 25.77%Upside | Reiterated | Macquarie | ||
| Unknown AnalystNot Ranked | 09/30/26 | MXN 202.67→MXN 238.44 | sell | -6.84%Downside | Reiterated | Daiwa | ||
| Unknown AnalystNot Ranked | 09/14/26 | MXN 290.90 | hold | 13.66%Upside | Reiterated | Mizuho Securities | ||
| Unknown AnalystNot Ranked | 08/18/26 | MXN 357.66 | buy | 39.74%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 08/17/26 | MXN 274.21→MXN 298.05 | hold | 16.45%Upside | Reiterated | J.P. Morgan | ||
| Hidemaru Yamaguchi | 08/07/26 | MXN 294.47 | hold | 15.06%Upside | Reiterated | Citi | ||
| Unknown AnalystNot Ranked | 08/06/26 | MXN 357.66→MXN 369.58 | buy | 44.40%Upside | Reiterated | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 08/06/26 | MXN 262.28 | hold | 2.48%Upside | Reiterated | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 07/29/26 | MXN 269.44 | hold | 5.27%Upside | Reiterated | SBI Securities | ||
| Unknown AnalystNot Ranked | 07/15/26 | MXN 286.13→MXN 274.21 | hold | 7.14%Upside | Reiterated | UBS | ||
| Miki Sogi | 07/07/26 | MXN 262.28 | hold | 2.48%Upside | Reiterated | Bernstein | ||
| Unknown AnalystNot Ranked | 06/05/26 | MXN 321.89 | buy | 25.77%Upside | Reiterated | Bank of America Securities | ||
| Stephen Barker | 03/24/26 | MXN 333.82 | buy | 30.43%Upside | Reiterated | Jefferies | ||
| Unknown AnalystNot Ranked | 02/19/26 | MXN 286.13→MXN 298.05 | hold | 16.45%Upside | Downgraded | Nomura | ||
| Unknown AnalystNot Ranked | 02/16/26 | MXN 202.67→MXN 238.44 | hold | -6.84%Downside | Reiterated | SMBC Nikko |
Best Analysts Covering Astellas Pharma
Copying OpenAI Drug Manufacturers - General's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of -0.03% per trade.
Copying OpenAI Drug Manufacturers - General's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +10.53% per trade.
Copying OpenAI Drug Manufacturers - General's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +10.53% per trade.
4503N Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 |
| Buy | 4 | 3 | 3 | 2 | 2 |
| Hold | 6 | 8 | 8 | 7 | 4 |
| Sell | 0 | 1 | 1 | 2 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 10 | 12 | 13 | 12 | 8 |
In the current month, 4503N has received 3 Buy Ratings, 4 Hold Ratings, and 1 Sell Ratings. 4503N average Analyst price target in the past 3 months is 304.16.
4503N Financial Forecast
4503N Earnings Forecast
Next quarter’s earnings estimate for 4503N is MXN 7.75 with a range of MXN 7.15 to MXN 8.60. The previous quarter’s EPS was MXN 9.44. 4503N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 4503N has Performed in-line its overall industry.
4503N Sales Forecast
Next quarter’s sales forecast for 4503N is MXN 70.64B with a range of MXN 65.41B to MXN 73.31B. The previous quarter’s sales results were MXN 76.42B. 4503N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 4503N has Performed in-line its overall industry.